Last reviewed · How we verify

NCT04969003

Reducing Transphobia Among Adolescents Through a Brief Video Intervention

Completed NA Last updated 3 May 2022
What this trial tests

NA trial testing Short videos in Transgenderism in 200 participants. Completed in 20 April 2022.

Timeline
1 March 2022
Primary endpoint
20 April 2022
20 April 2022

Quick facts

Lead sponsorYale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment200
Start date1 March 2022
Primary completion20 April 2022
Estimated completion20 April 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Yale University

Who can join

Adults 14 to 18, any sex, with Transgenderism or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purposes of this new study are to test among adolescent viewers the utility of brief video-based interventions to: 1. reduce transphobia; 2. reduce depression-related stigma and increase likelihood of treatment-seeking; and 3. examine the role of viewer's sex (male / female / non-binary), race (Black vs non-Black), and sexual orientation (straight vs LGBQ) as independent factors on the outcomes of interest.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of a Brief Social Contact Video on Transphobia and Depression-Related Stigma Among Adolescents: A Randomized Clinical Trial.
    Amsalem D, Halloran J, Penque B, Celentano J, et al · · 2022 · cited 30× · PMID 35212749 · DOI 10.1001/jamanetworkopen.2022.0376

Verify or expand the search:

Other trials of Short videos

Trials testing the same drug.

Other recruiting trials for Transgenderism

Currently open trials in the same condition.

Other Yale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing